Engineering Liver-Specific Promoters: A Comprehensive Review of Design, Mechanisms, and Clinical Applications in Gene Therapy
Cells · 22.12.2025 · 15 (1) · 14
DOI: 10.3390/cells15010014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 22.12.2025. Verfasst von Valentin Artemyev und 9 weiteren Autor:innen. Beteiligte Einrichtung: Moscow Center for Advanced Studies, Kulakova Str. 20, Moscow 123592, Russia. Hauptthemen laut MEDLINE: Genetic Therapy, Liver, Promoter Regions, Genetic, Genetic Engineering. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 397 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
The liver is a primary metabolic hub and a pivotal target for gene therapy, owing to its capacity for protein secretion, role in metabolic homeostasis and immune tolerance. Liver-directed gene therapies are used to treat numerous inherited metabolic disorders and coagulation factor deficiencies including hemophilia (A and B), Crigler–Najjar syndrome, mucopolysaccharidoses, phenylketonuria, Fabry, Gaucher, Wilson and Pompe diseases. The efficacy and safety of liver-directed gene therapy rely on the use of strong tissue-specific promoters. To date, there are many different liver-specific promoters used in preclinical and clinical studies, including novel completely synthetic promoters. This review provides a comprehensive analysis of the design, engineering and application of liver-specific promoters. Furthermore, we discuss fundamental principles of gene expression regulation in the liver and the physiological and immunological characteristics that make it a suitable target organ for gene therapy delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Moscow Center for Advanced Studies, Kulakova Str. 20, Moscow 123592, Russia.
- Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Moscow 125315, Russia.
- Moscow Clinical Scientific Center N.A. A.S. Loginov, Moscow 111123, Russia.
ORCID-Profile: Valentin Artemyev, Anastasiia Iu Paremskaia, Amina A Dzhioeva, Daria Mishina, Viktor Bogdanov, Julia Krupinova, Ali Mazloum, Sofya G Feoktistova, Olga N Mityaeva, Pavel Yu Volchkov
Förderung
- Russian Science Foundation
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Artemyev, V., Paremskaia, A. I., Dzhioeva, A. A., Mishina, D., Bogdanov, V., Krupinova, J., Mazloum, A., Feoktistova, S. G., Mityaeva, O. N., & Volchkov, P. Y. (2025). Engineering Liver-Specific Promoters: A Comprehensive Review of Design, Mechanisms, and Clinical Applications in Gene Therapy. Cells, 15(1), 14. https://doi.org/10.3390/cells15010014
Vancouver
Artemyev V, Paremskaia AI, Dzhioeva AA, Mishina D, Bogdanov V, Krupinova J, et al. Engineering Liver-Specific Promoters: A Comprehensive Review of Design, Mechanisms, and Clinical Applications in Gene Therapy. Cells. 2025;15(1):14. doi:10.3390/cells15010014
BibTeX
@article{Artemyev2025,
author = {Artemyev, Valentin and Paremskaia, Anastasiia Iu and Dzhioeva, Amina A and Mishina, Daria and Bogdanov, Viktor and Krupinova, Julia and Mazloum, Ali and Feoktistova, Sofya G and Mityaeva, Olga N and Volchkov, Pavel Yu},
title = {Engineering Liver-Specific Promoters: A Comprehensive Review of Design, Mechanisms, and Clinical Applications in Gene Therapy},
journal = {Cells},
year = {2025},
volume = {15},
number = {1},
pages = {14},
doi = {10.3390/cells15010014}
}
EUVIMED